rs804290
Positions:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The ENST00000532059.6(GATA4):c.*852G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.161 in 152,750 control chromosomes in the GnomAD database, including 2,624 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.16 ( 2607 hom., cov: 33)
Exomes 𝑓: 0.20 ( 17 hom. )
Consequence
GATA4
ENST00000532059.6 3_prime_UTR
ENST00000532059.6 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.935
Genes affected
GATA4 (HGNC:4173): (GATA binding protein 4) This gene encodes a member of the GATA family of zinc-finger transcription factors. Members of this family recognize the GATA motif which is present in the promoters of many genes. This protein is thought to regulate genes involved in embryogenesis and in myocardial differentiation and function, and is necessary for normal testicular development. Mutations in this gene have been associated with cardiac septal defects. Additionally, alterations in gene expression have been associated with several cancer types. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BP6
Variant 8-11759327-G-A is Benign according to our data. Variant chr8-11759327-G-A is described in ClinVar as [Benign]. Clinvar id is 433024.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-11759327-G-A is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.238 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GATA4 | NM_001308093.3 | c.*852G>A | 3_prime_UTR_variant | 7/7 | ENST00000532059.6 | NP_001295022.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GATA4 | ENST00000532059.6 | c.*852G>A | 3_prime_UTR_variant | 7/7 | 1 | NM_001308093.3 | ENSP00000435712 | A1 | ||
GATA4 | ENST00000335135.8 | c.*852G>A | 3_prime_UTR_variant | 7/7 | 5 | ENSP00000334458 | P3 | |||
GATA4 | ENST00000528712.5 | c.*852G>A | 3_prime_UTR_variant | 7/7 | 2 | ENSP00000435043 | ||||
GATA4 | ENST00000622443.3 | c.*852G>A | 3_prime_UTR_variant | 8/8 | 5 | ENSP00000482268 | P3 |
Frequencies
GnomAD3 genomes AF: 0.161 AC: 24477AN: 152116Hom.: 2614 Cov.: 33
GnomAD3 genomes
AF:
AC:
24477
AN:
152116
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.202 AC: 104AN: 516Hom.: 17 Cov.: 0 AF XY: 0.210 AC XY: 77AN XY: 366
GnomAD4 exome
AF:
AC:
104
AN:
516
Hom.:
Cov.:
0
AF XY:
AC XY:
77
AN XY:
366
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.161 AC: 24465AN: 152234Hom.: 2607 Cov.: 33 AF XY: 0.153 AC XY: 11413AN XY: 74428
GnomAD4 genome
AF:
AC:
24465
AN:
152234
Hom.:
Cov.:
33
AF XY:
AC XY:
11413
AN XY:
74428
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
267
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Pathogenic:1Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Congenital heart disease Pathogenic:1Benign:1
Pathogenic, no assertion criteria provided | clinical testing | Central Research Laboratory, Sri Devaraj Urs Academy of Higher Education and Research | Jan 07, 2017 | - - |
Benign, no assertion criteria provided | curation | Reproductive Health Research and Development, BGI Genomics | Jan 06, 2020 | NM_002052.3:c.*852G>A in the gene GATA4 has an allele frequency of 0.228 in European (non-Finnish) subpopulation in the gnomAD database. 460 homozygous occurrences are observed in the gnomAD database. This evidence suggests the variant to be classified as benign. ACMG/AMP criteria applied: BA1; BS2. - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 12, 2021 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
GATA4-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 16, 2021 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at